| 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer C Kratochwil, P Flechsig, T Lindner, L Abderrahim, A Altmann, W Mier, ... Journal of Nuclear Medicine 60 (6), 801-805, 2019 | 997 | 2019 |
| TERT promoter mutations and risk of recurrence in meningioma F Sahm, D Schrimpf, A Olar, C Koelsche, D Reuss, J Bissel, A Kratz, ... Journal of the National Cancer Institute 108 (5), djv377, 2016 | 356 | 2016 |
| FAPI-74 PET/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients FL Giesel, S Adeberg, M Syed, T Lindner, LD Jiménez-Franco, ... Journal of Nuclear Medicine 62 (2), 201-207, 2021 | 188 | 2021 |
| A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? S Adeberg, T Bostel, L König, T Welzel, J Debus, SE Combs Radiation oncology 9, 1-6, 2014 | 164 | 2014 |
| Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas—clinical results in 85 patients treated in a single institution leading to optimized … S Adeberg, C Hartmann, T Welzel, S Rieken, D Habermehl, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), 859-864, 2012 | 164 | 2012 |
| Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated … SE Combs, S Adeberg, JO Dittmar, T Welzel, S Rieken, D Habermehl, ... Radiotherapy and Oncology 106 (2), 186-191, 2013 | 135 | 2013 |
| Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers M Syed, P Flechsig, J Liermann, P Windisch, F Staudinger, S Akbaba, ... European journal of nuclear medicine and molecular imaging 47, 2836-2845, 2020 | 133 | 2020 |
| The role of 68Ga-FAPI PET/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience SA Koerber, F Staudinger, C Kratochwil, S Adeberg, MF Haefner, ... Journal of Nuclear Medicine 61 (9), 1331-1336, 2020 | 124 | 2020 |
| Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone S Adeberg, L König, T Bostel, S Harrabi, T Welzel, J Debus, SE Combs International Journal of Radiation Oncology* Biology* Physics 90 (4), 886-893, 2014 | 123 | 2014 |
| Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma SB Harrabi, N Bougatf, A Mohr, T Haberer, K Herfarth, SE Combs, ... Strahlentherapie und Onkologie 192 (11), 759, 2016 | 118 | 2016 |
| IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT M Röhrich, A Loktev, AK Wefers, A Altmann, D Paech, S Adeberg, ... European journal of nuclear medicine and molecular imaging 46, 2569-2580, 2019 | 102 | 2019 |
| Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients S Regnery, S Adeberg, C Dreher, J Oberhollenzer, JE Meissner, ... Oncotarget 9 (47), 28772, 2018 | 75 | 2018 |
| Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles C Koelsche, V Hovestadt, DTW Jones, D Capper, D Sturm, F Sahm, ... Brain pathology 25 (2), 202-208, 2015 | 75 | 2015 |
| Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T JE Meissner, A Korzowski, S Regnery, S Goerke, J Breitling, RO Floca, ... Journal of Magnetic Resonance Imaging 50 (4), 1268-1277, 2019 | 73 | 2019 |
| Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects SB Harrabi, S Adeberg, T Welzel, S Rieken, D Habermehl, J Debus, ... Radiation Oncology 9, 1-7, 2014 | 68 | 2014 |
| Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche S Chiblak, Z Tang, D Lemke, M Knoll, I Dokic, R Warta, M Moustafa, ... JCI insight 4 (2), 2019 | 63 | 2019 |
| Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution BA Högerle, F Lasitschka, T Muley, N Bougatf, K Herfarth, S Adeberg, ... Radiation Oncology 14, 1-9, 2019 | 60 | 2019 |
| Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma S Adeberg, SB Harrabi, N Bougatf, D Bernhardt, J Rieber, SA Koerber, ... Strahlentherapie und Onkologie 192 (11), 770, 2016 | 58 | 2016 |
| Treatment of meningioma and glioma with protons and carbon ions S Adeberg, SB Harrabi, V Verma, D Bernhardt, N Grau, J Debus, ... Radiation oncology 12, 1-7, 2017 | 52 | 2017 |
| Fibroblast activation protein (FAP) specific PET for advanced target volume delineation in glioblastoma P Windisch, M Röhrich, S Regnery, E Tonndorf-Martini, T Held, K Lang, ... Radiotherapy and Oncology 150, 159-163, 2020 | 49 | 2020 |
